The Disseminated Intravascular Coagulation (DIC) Market on a global scale was estimated at USD 437.3 Mn in 2023 and is poised to attain USD 563.8 Mn by 2031, with a projected CAGR of 3.3% between 2024 and 2031.
Disseminated Intravascular Coagulation (DIC) covers The Disseminated Intravascular Coagulation (DIC) market focuses on managing a serious condition characterized by abnormal blood clotting, involving key segments such as diagnostics (e.g., D-dimer test. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is bolstered by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Disseminated intravascular coagulation (DIC) Market Snapshot
Chapter 4. Global Disseminated intravascular coagulation (DIC) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Symptoms Estimates & Trend Analysis
5.1. by Symptoms & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Symptoms:
5.2.1. Bleeding
5.2.2. Blood Clots
5.2.3. Bruising
5.2.4. Drop in Blood Pressure
5.2.5. Shortness of Breath
5.2.6. Confusion
Chapter 6. Market Segmentation 2: by Distribution Channel Estimates & Trend Analysis
6.1. by Distribution Channel & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
6.2.1. Hospital Pharmacy
6.2.2. Retail Pharmacy
6.2.3. Online Pharmacy
6.2.4. Others
Chapter 7. Market Segmentation 3: by Diagnosis Estimates & Trend Analysis
7.1. by Diagnosis & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Diagnosis:
7.2.1. Complete Blood Count with Blood Smear Exam
7.2.2. Partial Thromboplastin Time (PTT)
7.2.3. Prothrombin Time (PT)
7.2.4. Fibrinogen Blood Test
7.2.5. D-dimer
7.2.6. Others
Chapter 8. Market Segmentation 4: by End-User Estimates & Trend Analysis
8.1. by End-User & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
8.2.1. Hospitals
8.2.2. Specialty Clinics
8.2.3. Homecare
8.2.4. Others
Chapter 9. Market Segmentation 5: by Treatment Estimates & Trend Analysis
9.1. by Treatment & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment:
9.2.1. Medicines
9.2.2. Transfusions
9.2.3. Surgery
9.2.4. Others
Chapter 10. Market Segmentation 6: by Route of Administration Estimates & Trend Analysis
10.1. by Route of Administration & Market Share, 2019 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
10.2.1. Oral
10.2.2. Parenteral
10.2.3. Others
Chapter 11. Disseminated intravascular coagulation (DIC) Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.1.2. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.1.3. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.1.4. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.1.5. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.1.6. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.1.7. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.2. Europe
11.2.1. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.2.2. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.2.3. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.2.4. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.2.5. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.2.6. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.2.7. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.3.2. Asia Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.3.3. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.3.4. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.3.5. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.3.6. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.3.7. Asia Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.4. Latin America
11.4.1. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.4.2. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.4.3. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.4.4. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.4.5. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.4.6. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.4.7. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.5.2. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.5.3. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.5.4. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.5.5. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.5.6. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.5.7. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Moderna, Inc.
12.2.2. Alnylam Pharmaceuticals, Inc.
12.2.3. Sanofi
12.2.4. Olix Pharmaceuticals, Inc.
12.2.5. Glaxosmithkline Plc.
12.2.6. Benitec Biopharma
12.2.7. Arbutus Biopharma Corporation
12.2.8. Silence Therapeutics
12.2.9. Rexahn Pharmaceuticals, Inc.
12.2.10. Arrowhead Pharmaceuticals, Inc.
12.2.11. Quark
12.2.12. Dicerna Pharmaceuticals (Novo Nordisk A/S)
12.2.13. Thermo Fisher Scientific Inc
12.2.14. Other Prominent Players